{"database": "openregs", "table": "dockets", "rows": [["FDA-2003-D-0373", "FDA", "Draft Guidance for Industry and FDA Staff; Premarket Submissions and Labeling Recommendations for Drugs of Abuse Screening Tests; Availability", "Nonrulemaking", "2021-09-01T01:03:12Z", "0b00006480499061"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2003-D-0373"], "units": {}, "query_ms": 0.3765069996006787, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}